Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible : A single-center report about outcome and toxicity.

Lang K, Akbaba S, Held T, Kargus S, Horn D, Bougatf N, Bernhardt D, Freier K, Rieken S, Debus J, Adeberg S.

Strahlenther Onkol. 2019 Jul 2. doi: 10.1007/s00066-019-01484-z. [Epub ahead of print]

PMID:
31267170
2.

Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.

Akbaba S, Ahmed D, Lang K, Held T, Mattke M, Hoerner-Rieber J, Herfarth K, Rieken S, Plinkert P, Debus J, Adeberg S.

Oral Oncol. 2019 Apr;91:39-46. doi: 10.1016/j.oraloncology.2019.02.019. Epub 2019 Feb 27.

PMID:
30926061
3.

Clinical Management of Blood⁻Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.

Held T, Akbaba S, Lang K, Harrabi S, Bernhardt D, Freudlsperger C, Kargus S, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 19;11(3). pii: E383. doi: 10.3390/cancers11030383.

4.

Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.

Akbaba S, Held T, Lang K, Forster T, Federspil P, Herfarth K, Häfner M, Plinkert P, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 17;11(3). pii: E379. doi: 10.3390/cancers11030379.

5.

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.

Akbaba S, Held T, Lang K, Hoerner-Rieber J, Zaoui K, Forster T, Rieken S, Plinkert P, Debus J, Adeberg S.

Radiat Oncol. 2019 Feb 19;14(1):34. doi: 10.1186/s13014-019-1238-8.

6.

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety.

Akbaba S, Lang K, Held T, Herfarth K, Rieber J, Plinkert P, Auffarth GU, Rieken S, Debus J, Adeberg S.

Cancer Manag Res. 2019 Feb 1;11:1155-1166. doi: 10.2147/CMAR.S190051. eCollection 2019.

7.

The role of organ- and function-preserving radiotherapy in the treatment of adenoid cystic carcinoma of the larynx.

Akbaba S, Lang K, Bulut OC, Held T, Rieken S, Plinkert P, Jensen A, Herfarth K, Debus J, Adeberg S.

Head Neck. 2019 Jul;41(7):2208-2214. doi: 10.1002/hed.25678. Epub 2019 Feb 5.

PMID:
30723979
8.

An Unusual Complication of Pericarditis.

Rad A, Lange U, Makowski B, Held T, Schönwälder J, Schmoeckel M.

Thorac Cardiovasc Surg Rep. 2018 Jan;7(1):e50-e52. doi: 10.1055/s-0038-1676034. Epub 2018 Dec 12.

9.

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity.

Lang K, Baur M, Akbaba S, Held T, Kargus S, Bougatf N, Bernhardt D, Freier K, Plinkert PK, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2018 Dec 4;10(12). pii: E488. doi: 10.3390/cancers10120488.

10.

Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution's Clinical Experience.

Liermann J, Syed M, Held T, Bernhardt D, Plinkert P, Jungk C, Unterberg A, Rieken S, Debus J, Herfarth K, Adeberg S.

Cancers (Basel). 2018 Nov 20;10(11). pii: E457. doi: 10.3390/cancers10110457.

11.

Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety.

Akbaba S, Lang K, Held T, Bulut OC, Mattke M, Uhl M, Jensen A, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2018 Oct 18;10(10). pii: E388. doi: 10.3390/cancers10100388.

12.

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms.

Kutsch N, Marks R, Ratei R, Held TK, Schmidt-Hieber M.

Biomark Insights. 2015 Aug 16;10(Suppl 3):15-23. doi: 10.4137/BMI.S22434. eCollection 2015. Review.

13.

Acquired deficiency of coagulation factor XIII--possible evidence for a new link between coagulation and infection from a case.

Lodemann P, Kolbeck H, Held TK, Ivaskevicius V, Oldenburg J, Schweigerer L, Ludwig WD, Peetz D.

Ann Hematol. 2013 Mar;92(3):427-9. doi: 10.1007/s00277-012-1582-3. Epub 2012 Sep 28. No abstract available.

PMID:
23053180
14.

Pharmacodynamic effects of haematopoietic cytokines: the view of a clinical oncologist.

Held TK, Gundert-Remy U.

Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):210-4. doi: 10.1111/j.1742-7843.2009.00514.x. Epub 2009 Dec 29. Review.

15.

[The risks of suboptimal medication prescribing resulting from economic restraints].

Held T.

Z Evid Fortbild Qual Gesundhwes. 2008;102(9):587-90; discussion 593, 606-8. German.

PMID:
19213456
16.

Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.

Horzempa J, Held TK, Cross AS, Furst D, Qutyan M, Neely AN, Castric P.

Clin Vaccine Immunol. 2008 Apr;15(4):590-7. doi: 10.1128/CVI.00476-07. Epub 2008 Feb 13.

17.

Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation.

Janitschke K, Held T, Krüiger D, Schwerdtfeger R, Schlier G, Liesenfeld O.

Clin Lab. 2003;49(5-6):239-42.

PMID:
15285180
18.

K-antigen-specific, but not O-antigen-specific natural human serum antibodies promote phagocytosis of Klebsiella pneumoniae.

Lepper PM, Möricke A, Held TK, Schneider EM, Trautmann M.

FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):93-8.

19.

Recruitment of murine neutrophils in vivo through endogenous sialidase activity.

Cross AS, Sakarya S, Rifat S, Held TK, Drysdale BE, Grange PA, Cassels FJ, Wang LX, Stamatos N, Farese A, Casey D, Powell J, Bhattacharjee AK, Kleinberg M, Goldblum SE.

J Biol Chem. 2003 Feb 7;278(6):4112-20. Epub 2002 Nov 22.

20.

Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia.

Kreuzer KA, Schmidt CA, Schetelig J, Held TK, Thiede C, Ehninger G, Siegert W.

Eur J Haematol. 2002 Jul;69(1):7-10.

PMID:
12270056

Supplemental Content

Loading ...
Support Center